Health & Biotech
ScoPo’s Powerplays: ASX health stocks… could be worse
Weed Week: A ‘shroom boom’ could see psychedelics follow cannabis’ explosive footsteps
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough
ASX Health Stocks: Paradigm Bio says drug effective in dogs, HeraMED signs deal in US
ASX Health Stocks: Zelira skyrockets 200pc after saying that its drug works better than Pfizer’s Lyrica
First UK patients receive MGC Pharma’s CannEpil product
World renowned psychedelics experts join Incannex’s Clarion Clinics advisory board
ASX Health Stocks: Neurotech gets approval to treat children patients until they are 20 years old
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
ASX Health Stocks: Tissue Repair and Radiopharm jump double digits after US FDA meetings
Wellnex to buy leading Australian pain relief brand Pain Away for $22 million
ScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good news
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
ASX Health Stocks: Patrys, Immutep jump after reports show drugs well tolerated
ASX Health Stocks: 4DMedical makes breakthrough, potentially disrupts century-old method
Pop the champagne as EBR becomes latest ASX biotech to achieve key catalyst
PharmAust confirms safety of MPL, poised to up dosage in MND trial
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
